Value of estimated glucose disposal rate to detect prevalent left ventricular hypertrophy: implications from a general population

References

• Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990 May 31 322(22):1561–1566.
   PubMed Web of Science ®Google Scholar
• Drazner MH, Rame JE, Marino EK, et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the cardiovascular health study. J Am Coll Cardiol. [2004 Jun 16];43(12):2207–2215.
   PubMed Web of Science ®Google Scholar
• Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham heart study. Jama. [1994 Jul 6];272(1):33–36.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Bavishi C, Sardar P, et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am J Cardiol. [2014 Oct 1];114(7):1049–1052.
   PubMed Web of Science ®Google Scholar
• Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population; The Tromsø study. Eur Heart J. 1999 Mar;20(6):429–438.
   PubMed Web of Science ®Google Scholar
• Félix-Redondo FJ, Fernández-Bergés D, Calderón A, et al. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: hermex study. J Hypertens. 2012 Jul;30(7):1460–1467.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Sala C, Negri F, et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012 Jun;26(6):343–349.
   PubMed Web of Science ®Google Scholar
• Dawson A, Morris AD, Struthers AD. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia. 2005 Oct;48(10):1971–1979.
   PubMed Web of Science ®Google Scholar
• Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004 Aug;25(4):543–567.
   PubMed Web of Science ®Google Scholar
• Anderson EA, Hoffman RP, Balon TW, et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991 Jun;87(6):2246–2252.
   PubMed Web of Science ®Google Scholar
• Falcão-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev. 2012 May;17(3):325–344.
   PubMed Web of Science ®Google Scholar
• Cauwenberghs N, Knez J, Thijs L, et al. Relation of insulin resistance to longitudinal changes in left ventricular structure and function in a general population. J Am Heart Assoc. 2018 Mar 24;7:(7)
   Web of Science ®Google Scholar
• Kianu Phanzu B, Nkodila Natuhoyila A, Kintoki Vita E, et al. Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case-control study. BMC Cardiovasc Disord. [2021 Jan 2];21(1):1.
   PubMed Web of Science ®Google Scholar
• Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham heart study. Circulation. [2003 Jan 28];107(3):448–454.
   PubMed Web of Science ®Google Scholar
• Brown AJM, Gandy S, McCrimmon R, et al. A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial. Eur Heart J. [2020 Sep 21];41(36):3421–3432.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–23.
   PubMed Web of Science ®Google Scholar
• Williams KV, Erbey JR, Becker D, et al. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000 Apr;49(4):626–632.
   PubMed Web of Science ®Google Scholar
• Nyström T, Holzmann MJ, Eliasson B, et al. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab. 2018 Mar;20(3):556–563.
   PubMed Web of Science ®Google Scholar
• Zabala A, Darsalia V, Lind M, et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. [2021 Oct 6];20(1):202.
   PubMed Web of Science ®Google Scholar
• Helliwell R, Warnes H, Kietsiriroje N, et al. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: beyond glycated haemoglobin. Diabet Med. 2021 May;38(5):e14529.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Roman MJ. Evaluation of the heart and arterial tree in hypertension. J Cardiovasc Risk. 1995 Feb;2(1):4–15.
   PubMedGoogle Scholar
• Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358–367.
   PubMedGoogle Scholar
• Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003 Jan;26(1):S5–20.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. [2014 Feb 5];311(5):507–520.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. [1986 Feb 15];57(6):450–458.
   PubMed Web of Science ®Google Scholar
• Wang H, Sun Y, Li Z, et al. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. BMC Cardiovasc Disord. [2018 Apr 10];18(1):62.
   PubMed Web of Science ®Google Scholar
• Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1–36.
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007 Feb 20;115(7):928–935.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol. 2012 Aug;7(8):1355–1364.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr., D’Agostino RB Jr., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008 Jan 30;27(2):157–172. discussion 207-12.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB, Steyerberg EW S. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011 Jan 15;30(1):11–21.
   PubMed Web of Science ®Google Scholar
• Grunkemeier GL, Jin R. Net reclassification index: measuring the incremental value of adding a new risk factor to an existing risk model. Ann Thorac Surg. 2015 Feb;99(2):388–392.
   PubMed Web of Science ®Google Scholar
• Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008 Jan 15;51(2):93–102.
   PubMed Web of Science ®Google Scholar
• An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1489–506.
   PubMed Web of Science ®Google Scholar
• Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017 Mar 15;113(4):389–398.
   PubMed Web of Science ®Google Scholar
• Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016 Mar;12(3):144–153.
   PubMed Web of Science ®Google Scholar
• Paolillo S, Rengo G, Pagano G, et al. Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care. 2013 Aug;36(8):2395–2401.
   PubMed Web of Science ®Google Scholar
• Paolillo S, Rengo G, Pellegrino T, et al. Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure. Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1148–1153.
   PubMed Web of Science ®Google Scholar
• Gottsäter M, Östling G, Persson M, et al. Non-hemodynamic predictors of arterial stiffness after 17 years of follow-up: the Malmö Diet and cancer study. J Hypertens. 2015 May;33(5):957–965.
   PubMed Web of Science ®Google Scholar
• Poon AK, Meyer ML, Tanaka H, et al. Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the atherosclerosis risk in communities study. Cardiovasc Diabetol. [2020 Jan 28];19(1):11.
   PubMed Web of Science ®Google Scholar
• Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.
   PubMed Web of Science ®Google Scholar
• Weber T, Protogerou A. Left ventricular hypertrophy, arterial stiffness and blood pressure: exploring the Bermuda Triangle. J Hypertens. 2019 Feb;37(2):280–281.
   PubMed Web of Science ®Google Scholar